Previous close | 12.50 |
Open | 12.50 |
Bid | 12.50 x 0 |
Ask | 13.00 x 0 |
Day's range | 12.30 - 12.85 |
52-week range | 5.80 - 12.85 |
Volume | |
Avg. volume | 2,038,244 |
Market cap | 89.593M |
Beta (5Y monthly) | 1.17 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.17 |
Earnings date | 28 Sept 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 52.00 |
Key Insights Shield Therapeutics' significant private companies ownership suggests that the key decisions are...
Premier Miton Group Plc - Form 8.3 - Shield Therapeutics plc
Killik & Co. LLP - Form 8.3 - Shield Therapeutics Plc